Abstract:
A motor vehicle entertainment system includes a radio receiver and a control unit. The control unit receives a first status signal indicative of whether or not a motor vehicle door has been unlocked and initiates the application of power to the radio receiver upon the first status signal indicating that the door has been unlocked. Upon the application of power to the radio receiver, the radio receiver scans through a selected frequency spectrum to identify valid frequencies and their associated broadcast identifying information and stores a list of the valid frequencies and their associated broadcast identifying information in a memory device associated with the radio receiver. The radio receiver acquires and records information on a plurality of transmitters initially in a standby mode before it switches over to an operating mode. The radio receiver has a device for receiving an ON command from the user and switches from the standby mode to the operating mode when the ON command is received. The radio receiver may begin to operate before the ON command is input by the user, and independently of this input. If the radio receiver begins to operate in sufficient time before input of the ON command, then collection of transmitter information by the radio receiver may already be complete before the user inputs the ON command, which is typically indicative of the desire of the user to listen to an audio signal.
Abstract:
A method for analyzing the identity, protein and/or peptide pattern and also the stability of samples containing physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity, particularly mixtures of digestive enzymes such as pancreatin, for use in manufacturing medicinal products comprising such enzyme mixtures, e.g. precipitated pancreatin or pancreatin mini-microspheres.
Abstract:
An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
Abstract:
In an arrangement and method for active vibration compensation of an x-ray radiator, a counter-vibration generation unit is arranged within the x-ray radiator to reduce a vibration arising during operation of the x-ray radiator. The counter-vibration generating unit is engaged in an active connection with the x-ray radiator and generates a counter-vibration that is phase-shifted by 180 degrees relative to the operational vibration. Operational vibrations generated by the x-ray radiator can be directly reduced at the point of origin by the application of active counter-vibrations in the immediate proximity of the vibration generator. Additional vibration transmission to other system parts (for example a C-arm) is thereby reduced or prevented.
Abstract:
The sound reproduction of a multichannel sound reproduction system with a plurality of speakers which is connected to the output of an FM stereo receiver is controlled by a control signal derived from the reception quality. Preferably, the control signal from the FM stereo receiver for controlling the stereo and mono components is also employed to control the multichannel sound reproduction system. For example, stereo, pseudo-stereo or mono reproduction are provided in the multichannel sound reproduction system in response to the stereo component within the output signal.
Abstract:
In an arrangement and method for active vibration compensation of an x-ray radiator, a counter-vibration generation unit is arranged within the x-ray radiator to reduce a vibration arising during operation of the x-ray radiator. The counter-vibration generating unit is engaged in an active connection with the x-ray radiator and generates a counter-vibration that is phase-shifted by 180 degrees relative to the operational vibration. Operational vibrations generated by the x-ray radiator can be directly reduced at the point of origin by the application of active counter-vibrations in the immediate proximity of the vibration generator. Additional vibration transmission to other system parts (for example a C-arm) is thereby reduced or prevented.
Abstract:
Media content playback includes providing a plurality of media contents; providing for each of the media contents information identifying the respective media content; receiving from a user selection instructions that effect selecting or deselecting of a specific media content; providing context data based on measurements of at least one of absolute time, absolute position and of at least one physical quantity at or in the vicinity of the location where the selected media content is to be reproduced; providing or adapting a user profile that assigns for each specific media content user instructions to the context data provided at the time of receipt of the respective instruction; selecting according to the user profile one of the media contents dependent on the context data at the time of selection; and reproducing the selected media content.
Abstract:
The sound reproduction of a multichannel sound reproduction system with a plurality of speakers which is connected to the output of an FM stereo receiver is controlled by a control signal derived from the reception quality. Preferably, the control signal from the FM stereo receiver for controlling the stereo and mono components is also employed to control the multichannel sound reproduction system. For example, stereo, pseudo-stereo or mono reproduction are provided in the multichannel sound reproduction system in response to the stereo component within the output signal.
Abstract:
The present invention relates to pharmaceutical compositions comprising granules containing at least one recombinantly produced purified microbial lipase, the use of said pharmaceutical compositions for the manufacture of a medicament for the prevention or treatment of certain diseases or disorders like pancreatic endocrine insufficiency, and a process for the manufacture of said pharmaceutical compositions.
Abstract:
An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.